Announcements Trials
Browse Landscape

Phase

Phase 2 24Phase 3 7Phase 4 4Phase NA 2Phase EARLY_PHASE1 1Phase 1/2 1

Status

Unknown 3Completed 1

Sponsor Class

INDUSTRY 6OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Thoracic 3Tumor-Agnostic 1

Conditions

Neoplasms, Second Primary 1NSCLC 1Lung Neoplasms 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Dexamethasone 49Metformin 47Cyclophosphamide 42Saline Solution 38Cytarabine 34Sodium Chloride 32Bupivacaine 31Vincristine 27Cisplatin 26Propofol 25Methotrexate 25Letrozole 24Fluorouracil 24Dexmedetomidine 24Doxorubicin 23Fentanyl 22Carboplatin 22Etoposide 19Rituximab 18Morphine 18Bevacizumab 18Acetaminophen 18Lidocaine 17Granulocyte Colony-Stimulating Factor 17Prednisone 16Mercaptopurine 16Docetaxel 16Clomiphene 16Sevoflurane 15Ropivacaine 15

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 4 × OTHER × icotinib × Clear all
NCT02744664 2020-05-27

Cryotherapy Combine Icotinib for Advanced NSCLC Treatment

Fuda Cancer Hospital, Guangzhou

Phase 4 Completed
60 enrolled
Thoracic

Lung Neoplasms

NCT02778893 2016-05-20

Conmana Combined With Thalidomide to Treat NSCLC

Henan Provincial People's Hospital

Phase 4 Unknown
67 enrolled
Thoracic

NSCLC

NCT02031601 2016-03-29

TCL-1

Qilu Hospital of Shandong University

Phase 4 Unknown
250 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT02283424 2014-11-05

Icotinib as the Adjunctive Treatment After Surgery in Stage I-IIIB Lung Adenocarcinoma Patients With EGFR Gene Mutation

Chinese PLA General Hospital

Phase 4 Unknown
10 enrolled
Tumor-Agnostic

Neoplasms, Second Primary

Data powered by HemOnc (CC BY 4.0) Colophon âš¡